Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Voltage-gated sodium channel
Na
v
1.5 is critical for generation and conduction of cardiac action potentials. Mutations and expression level changes of Na
v
1.5 are associated with cardiac arrhythmias and sudden death. The ubiquitin (Ub) conjugation machinery utilizes three enzyme activities, E1, E2, and E3, to regulate protein degradation. Previous studies from us and others showed that Nedd4-2 acts as an E3
ubiquitin-protein ligase
involved in ubiquitination and degradation of Na
v
1.5, however, more key regulators remain to be identified. In this study, we show that UBC9, a SUMO-conjugating enzyme, regulates ubiquitination and degradation of Na
v
1.5. Overexpression of UBC9 significantly decreased Na
v
1.5 expression and reduced sodium current densities, whereas knockdown of UBC9 expression significantly enhanced Na
v
1.5 expression and increased sodium current densities, in both HEK293 cells and primary neonatal cardiomyocytes. Overexpression of UBC9 increased ubiquitination of Na
v
1.5, and proteasome inhibitor MG132 blocked the effect of UBC9 overexpression on Na
v
1.5 degradation. Co-immunoprecipitation showed that UBC9 interacts with Nedd4-2. UBC9 with mutation C93S, which suppresses SUMO-conjugating activity of UBC9, was as active as wild type UBC9 in regulating Na
v
1.5 levels, suggesting that UBC9 regulates Na
v
1.5 expression levels in a SUMOylation-independent manner. Our findings thus identify a key structural element of the ubiquitin-conjugation machinery for Na
v
1.5 and provide important insights into the regulatory mechanism for ubiquitination and turnover of Na
v
1.5.
...
PMID:UBC9 regulates cardiac sodium channel Na
v
1.5 ubiquitination, degradation and sodium current density. 3077 77
